The PE Ratio as of December 2025 (TTM) for Laboratorios Farmaceuticos Rovi, S.A. (LABFF) is 28.95

According to Laboratorios Farmaceuticos Rovi, S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 28.95. This represents a change of -0.99% compared to the average of 29.24 of the last 4 quarters.

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Historical PE Ratio (quarterly & annually)

How has LABFF PE Ratio performed in the past?

The mean historical PE Ratio of Laboratorios Farmaceuticos Rovi, S.A. over the last ten years is 30.09. The current 28.95 PE Ratio has changed 9.52% with respect to the historical average. Over the past ten years (40 quarters), LABFF's PE Ratio was at its highest in in the December 2017 quarter at 873.05. The PE Ratio was at its lowest in in the December 2022 quarter at 6.16.

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Laboratorios Farmaceuticos Rovi, S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Average PE Ratio

How has LABFF PE Ratio performed in the past?

The current PE Ratio of Laboratorios Farmaceuticos Rovi, S.A. (LABFF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) PE Ratio vs. Peers

How is LABFF’s PE Ratio compared to its peers?

Laboratorios Farmaceuticos Rovi, S.A.’s PE Ratio is less than ALK-Abelló A/S (49.98), greater than Genscript Biotech Corporation (0.73), greater than Shanghai Junshi Biosciences Co., Ltd. (-38.88), less than Camurus AB (publ) (46.07), greater than InnoCare Pharma Limited (-75.65), greater than Siegfried Holding AG (20.42), greater than Zealand Pharma A/S (5.38), less than Welcia Holdings Co., Ltd. (35.98), greater than COSMOS Pharmaceutical Corporation (18.97), greater than Carl Zeiss Meditec AG (25.29),

Build a custom stock screener for Laboratorios Farmaceuticos Rovi, S.A. (LABFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Laboratorios Farmaceuticos Rovi, S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Laboratorios Farmaceuticos Rovi, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.